Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.
Contact Us
Monday - Friday
Votrient 400 mg (Pazopanib) Tablet is a protein kinase inhibitor to handle kidney cancer and soft tissue sarcoma.
Availability: In Stock
| Indication | Kidney cancer |
|---|---|
| Strength | Pazopanib (400mg) |
| Manufacturer | Glaxo SmithKline Pharmaceuticals Ltd |
| Pharmaceutical Form | Tablet |
| Pack Size | 30 Tablet, 60 Tablet, 90 Tablet, 120 Tablet, 180 Tablet |
Reviews
There are no reviews yet.